Updated results from CHAMPION-1, a phase I/II study investigating weekly carfilzomib with dexamethasone for patients (Pts) with relapsed or refractory multiple myeloma (RRMM).
暂无分享，去创建一个
R. Rifkin | A. Cartmell | J. Berenson | M. Coleman | R. Lyons | D. Tzachanis | P. Patel | A. Bessudo | R. Boccia | J. Berdeja | W. Harb | S. Dixon